In this video from the American Society of Retina Specialists annual meeting, David A. Eichenbaum, MD, FASRS, discusses study ...

The FDA approved Tonmya, a first-in-class, non-opioid, once-daily bedtime analgesic, for the treatment of fibromyalgia in ...

The FDA approved the adenoviral vector-based immunotherapy, zopapogene imadenovec-drba, for treatment of certain patients ...

Ustekinumab and vedolizumab both demonstrated safety and efficacy in treating Crohn’s disease of the pouch, according to ...

The Infectious Diseases Society of America has begun updating its clinical practice guidelines for managing histoplasmosis ...

HHS Secretary Robert F. Kennedy Jr.’s decision to dismiss all 17 members of the CDC Advisory Committee on Immunization ...

Daily steps below the recommended 10,000 were still associated with lower risk for major heart-related events, even among ...

Laser therapy has been the subject of many legal cases brought against clinicians, according to a study published in the ...

Diet-driven metabolites had close associations with various blood-based biomarkers indicative of Alzheimer’s disease ...

An AI-powered OCT mapping method can help optimize epiretinal membrane peeling, according to a trial. “What we’re trying to ...

A randomized clinical trial set up to assess if dalbavancin is superior to standard treatment for Staphylococcus aureus ...

Failure rates in patients who had a documented seizure prior to a shoulder stabilization procedure are “unacceptably high,” ...